Kronos Bio Company
Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.
Investors
Headquarters:
San Mateo, California, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Technology:
Data-driven Technologies
Founded Date:
2017
Industry:
PharmTech